Combined, superselective pharmacological management of large coronary thrombus burden

Journal of Invasive Cardiology

Volumn 21, Issue 4, 2009, Pages 168-171

  Cortese, Bernardo ^a   Micheli, Andrea ^a   Picchi, Andrea ^a   Limbruno, Ugo ^a  

^a MISERICORDIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; UROKINASE; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; TICLOPIDINE;

ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; FOLLOW UP; HOSPITALIZATION; HUMAN; ISCHEMIA; PERCUTANEOUS CORONARY INTERVENTION; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; CORONARY THROMBOSIS; REGISTER; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; ASPIRIN; CORONARY THROMBOSIS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PLATELET AGGREGATION INHIBITORS; REGISTRIES; STENTS; TICLOPIDINE; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 67649603195     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Budde T, Haude M, Hopp HW, et al. A prognostic computer model to individually predict post-procedural complications in interventional cardiology: The INTERVENT Project. Eur Heart J 1999;20:354-363.
2. Chew D P, Bhatt DL, Robbins MA, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001;104:992-997.
3. Harrell L, Schunkert H, Palacios I F. Risk predictors in patients scheduled for percutaneous coronary revascularization. Catheter Cardiovasc Interv 1999;48:253-260.
4. Singh M, Lennon RJ, Holmes DR Jr, et al. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 2002;40:387-393.
5. Ali A, Cox D, Dib N, et al. For the AIMI Investigators. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 2006;48:244-252.
6. Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557-567.
7. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: A randomized controlled trial. JAMA 2005;293:1063-1072.
8. Kaltoft A, Bøttcher M, Nielsen SS, et al. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: A randomized, controlled trial. Circulation 2006;114:40-47.
9. Kuntz RE, Baim DS, Cohen DJ, et al. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J Cardiol 2002;89:326-330.
10. Collet J P, Beygui F, Barthelemy O, et al. Treatment of intracoronary thrombus in the catheterisation laboratory in acute coronary syndrome patients. Ann Cardiol Angeiol 2007;56:250-256.
11. Romagnoli E, Burzotta F, Trani C, et al. Rationale for intracoronary administration of abciximab. J Thromb Thrombolysis 2007;23:57-63.
12. Kindermann M, Adam O, Werner N, Bohm M. Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007: (FINESSE, CARESS, OASIS 5, PRAGUE-8, OPTIMIST, GRACE, STEEPLE, SCAAR, STRATEGY, DANAMI-2, ExTRACT-TIMI-25, ISAR-REACT 2, ACUITY, ALOFT, 3CPO, PROSPECT, EVEREST, COACH, BENEFiT, MERLIN-TIMI 36, SEARCH-MI, ADVANCE, WENBIT, EUROASPIRE I-III, ARISE, getABI, RIO). Clin Res Cardiol 2007;96:767-786.
13. Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial. Lancet 2001;357:1905-1914.
14. Kastrati A, Mehilli J, Schlotterbeck K, et al. Early administration of reteplase plus abcix-imab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: A randomized controlled trial. JAMA 2004;291:947-954.
15. Farrehi PM, Zhu Y, Fay W P. An analysis of mechanisms underlying the antifibrinolytic properties of radiographic contrast agents. J Thromb Thrombolysis 2001;12:273-281.
16. Halkin A, Keren G, Stone GW, et al. Coronary intervention in thrombus-rich lesions: Beyond stents and glycoprotein IIb/IIIa inhibitors. Isr Med Assoc J 2003;5:795-800.
17. Singh M, Reeder GS, Ohman EM, et al. Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An angio-graphic trials pool data experience. J Am Coll Cardiol 2001;38:624-630.
18. de la Torre-Hernández JM, Alfonso F, et al; ESTROFA Study Group. Drug-eluting stent thrombosis: Results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 2008;51:986-990.
19. Flores-Ríos X, Marzoa-Rivas R, Abugattás-de Torres J P, et al. Late thrombosis of pacli-taxel-eluting stents: Long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients. Am Heart J2008;155:648-653.
20. Slottow TL, Waksman R. Drug-eluting stent safety. Am J Cardiol 2007;100:10M-17M.
21. Kunadian B, Dunning J, Vijayalakshmi K, et al. Meta-analysis of randomized trials comparing anti-embolic devices with standard PCI for improving myocardial reperfusion in patients with acute myocardial infarction. Catheter Cardiovasc Interv 2007;69:488-496.
22. Brodie BR. Adjunctive thrombectomy with primary percutaneous coronary intervention for ST-elevation myocardial infarction: Summary of randomized trials. J Invasive Cardiol 2006;18(Suppl C):C24-C27.
23. De Luca G, Suryapranata H, Chiariello M. Prevention of distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction. A review of current status. Thromb Haemost 2006;96:700-710.
24. Limbruno U, De Caterina R. EMERALD, AIMI, and PROMISE: Is there still a potential for embolic protection in primary PCI? Eur Heart J 2006;27:1139-1145.
25. Kastrati A, Mehilli J, Neumann FJ, et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: The ISAR-REACT 2 randomized trial. JAMA 2006;295:1531-1538.
26. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifi-batide in patients with acute coronary syndromes. Platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy. N Engl J Med 1998;339:436-443.
27. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. N Engl J Med 1998;338:1498-1505.
28. Yip HK, Wu CJ, Chang HW, et al. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes. Chest 2003;124:962-968.
29. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomised trial. Lancet 2006;367:569-578.
30. Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985;6:556-585.
31. Moser M, Bertram U, Peter K, et al. Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates. J Cardiovasc Pharmacol 2003;41:586-592.
32. Steiner S, Seidinger D, Huber K, et al. Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression. Arterioscler Thromb Vasc Biol 2003;23:1697-1702.
33. Borden WB, Faxon D P. Facilitated percutaneous coronary intervention. J Am Coll Cardiol 2006;48:1120-1128.
34. Mitchel JF, Shwedick M, Alberghini TA, et al. Catheter-based local thrombolysis with urokinase: Comparative efficacy of intraluminal clot lysis with conventional urokinase infusion techniques in an in vivo porcine thrombus model. Cathet Cardiovasc Diagn 1997;41:293-302.
35. Yip HK, Chen MC, Chang H W, et al. Angiographic morphologic features of infarct-re-lated arteries and timely reperfusion in acute myocardial infarction: Predictors of slow-flow and no-reflow phenomenon. Chest 2002;122:1322-1332.
36. Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008 ;358:557-567.